Burning Rock Biotech Ltd (BNR) › Capital ExpendituresBurning Rock Biotech Ltd (BNR) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: 23.19M CNY2019: 42.97M CNY2020: 60.29M CNY2021: 204.33M CNY2022: 62.03M CNY2023: 8.10M CNY2024: 5.42M CNY2025: 5.25M CNY5.25M CNY2018Capital Expenditures (CNY)2025Fiscal YearCapital ExpendituresChange YoY20255.25M CNY-3.1%20245.42M CNY-33.1%20238.10M CNY-86.9%202262.03M CNY-69.6%2021204.33M CNY+238.9%202060.29M CNY+40.3%201942.97M CNY+85.3%201823.19M CNY—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share